Nociceptin modulates bronchoconstriction induced by sensory nerve activation in mouse lung

American Journal of Respiratory Cell and Molecular Biology

Volumn 42, Issue 2, 2010, Pages 250-254

  D'Agostino, Bruno ^a   Orlotti, Donatella ^a   Calò, Girolamo ^b   Sullo, Nikol ^a   Russo, Mariangela ^a   Guerrini, Remo ^b   De Nardo, Marilisa ^a   Mazzeo, Filomena ^c   Candeletti, Sanzio ^d   Rossi, Francesco ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b UNIVERSITY OF FERRARA   (Italy)

^c UNIVERSITY OF NAPLES PARTHENOPE   (Italy)

^d UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Airway responsiveness; Allergic asthma; Endogenous nociceptin orphanin FQ; Nociceptin orphanin FQ peptide receptor; Sensory nerves

Indexed keywords

CAPSAICIN; NOCICEPTIN; NOCICEPTIN RECEPTOR; NOCICEPTIN RECEPTOR AGONIST; NOCICEPTIN RECEPTOR ANTAGONIST; OVALBUMIN; PROTEIN DERIVATIVE; UNCLASSIFIED DRUG; UNIVERSITY OF FERRARA PEPTIDE 101;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BAGG ALBINO MOUSE; BRONCHOSPASM; C57BL 6 MOUSE; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; EXPERIMENTAL MODEL; EXPERIMENTAL MOUSE; LUNG FUNCTION; LUNG PARENCHYMA; MOUSE; NONHUMAN; PROTEIN FUNCTION; SENSORY NERVE CONDUCTION;

ALLERGENS; ANIMALS; BRONCHOCONSTRICTION; CAPSAICIN; LUNG; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; OPIOID PEPTIDES; OVALBUMIN; RECEPTORS, OPIOID; SENSORY RECEPTOR CELLS;

ANIMALIA; MUS;

EID: 74549185048     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2008-0488OC     Document Type: Article

References (26)

1. Meunier JC, Mollereau C, Toll C, Suaudeau C, Moisand C, Alvinerie P, Butour JL, Guillemot JC, Ferrara P, Monsarrat B, et al. Isolation and structure of the endogenous agonist of opioid receptor-Iike ORLI receptor. Nature 1995;377:532-535.
2. Mogil JS, Pasternak GW. The molecular and behavioral pharmacology of the orphanin FQ/nociceptin peptide and receptor family. Pharmacol Rev 2001;53:381-415. (Review).
3. Lapalu S, Moisand C, Butour JL, Mollereau C, Meunier JC. Different domains of the ORL1 and kappa-opioid receptors are involved in recognition of nociceptin and dynorphin A. FEBS Lett 1998;427: 296-300.
4. Nelson RM, Calò G, Guerrini R, Hainsworth AH, Green AR, Lambert DG. Nociceptin/orphanin FQ inhibits ischaemia-induced glutamate efflux from rat cerebrocortical slices. Neuroreport 2000;11:3689-3692.
5. Shah S, Page CP, Spina D. Nociceptin inhibits non-adrenergic noncholinergic contraction in guinea-pig airway. Br J Pharmacol 1998; 125:510-516.
6. Patel HJ, Giembycz MA, Spicuzza L, Barnes PJ, Belvisi MG. Naloxoneinsensitive inhibition of acetylcholine release from parasympathetic nerves innervating guinea-pig trachea by the novel opioid, nociceptin. Br J Pharmacol 1997;120:735-736.
7. Fischer A, Forssmann WG, Undem BJ. Nociceptin-induced inhibition of tachykinergic neurotransmission in guinea pig bronchus. J Pharmacol Exp Ther 1998;285:902-907.
8. Corboz MR, Rivelli MA, Egan RW, Tulshian D, Matasi J, Fawzi AB, Benbow L, Smith-Torhan A, Zhang H, Hey JA. Nociceptin inhibits capsaicin induced bronchoconstriction in isolated guinea pig lung. Eur J Pharmacol 2000;402:171-179.
9. Saria A, Martling CR, Yan Z, Theodorsson-Norheim E, Gamse R, Lundberg JM. Release of multiple tachykinins from capsaicin-sensitive sensory nerves in the lung by bradykinin, histamine, dimethylphenyl piperazinium, and vagal nerve stimulation. Am Rev Respir Dis 1988; 137:1330-1335.
10. Fischer A, Mcgregor GP, Saria A, Philippin B, Kummer W. Induction of tachykinin gene and peptide expression in guinea pig no dose primary afferent neurons by allergic airway inflammation. J Clin Invest 1996; 98:2284-2291.
11. Arduin M, Spagnolo B, Calò G, Guerrini R, Carrà G, Fischetti C, Trapella C, Marzola E, McDonald J, Lambert DG, et al. Synthesis and biological activity of nociceptin/orphanin FQ analogues substituted in position 7 or 11 with Calpha,alpha-dialkylated amino acids. Bioorg Med Chem 2007;15:4434-4443.
12. Rizzi A, Spagnolo B, Wainford RD, Fischetti C, Guerrini R, Marzola G, Baldisserotto A, Salvadori S, Regoli D, Kapusta DR, et al. In vitro and in vivo studies on UFP-112, a novel potent and long lasting agonist selective for the nociceptin/orphanin FQ receptor. Peptides 2007;28:1240-1251.
13. Calò G, Rizzi A, Rizzi D, Bigoni R, Guerrini R, Marzola G, Marti M, McDonald J, Morari M, Lambert DG, et al. [Nphe1,Arg14,Lys15] nociceptin-NH2, a novel potent and selective antagonist of the nociceptin/orphanin FQ receptor. Br J Pharmacol 2002;136:303-311.
14. Calò G, Guerrini R, Rizzi A, Salvadori S, Burmeister M, Kapusta DR, Lambert DG, Regoli D. UFP-101, a peptide antagonist selective for the nociceptin/orphanin FQ receptor. CNS Drug Rev 2005;11:97-112.
15. Nishi M, Houtani T, Noda Y, Mamiya T, Sato K, Doi T, Kuno J, Takeshima H, Nukada T, Nabeshima T, et al. Unrestrained nociceptive response and disregulation of hearing ability in mice lacking the nociceptin/orphanin FQ receptor. EMBO J 1997;16:1858-1864.
16. Gavioli EC, Rizzi A, Marzola G, Zucchini S, Regoli D, Calò G. Altered anxiety-related behavior in nociceptin/orphanin FQ receptor gene knockout mice. Peptides 2007;28:1229-1239.
17. Roviezzo F, Di Lorenzo A, Bucci M, Brancaleone V, Vellecco V, De Nardo M, Orlotti D, De Palma R, Rossi F, D'Agostino B, et al. Sphingosine-1-phosphate/sphingosine kinase pathway is involved in mouse airway hyperresponsiveness. Am J Respir Cell Mol Biol 2007; 36:757-762.
18. Aparicio LC, Candeletti S, Binaschi A, Mazzuferi M, Mantovani S, Di Benedetto M, Landuzzi D, Lopetuso G, Romualdi P, Simonato M. Kainate seizures increase nociceptin/orphanin FQ release in the rat hippocampus and thalamus: a microdialysis study. J Neurochem 2004; 91:30-37.
19. Ploj K, Roman E, Gustavsson L, Nylander I. Basal levels and alcoholinduced changes in nociceptin/orphanin FQ, dynorphin, and enkephalin levels in C57BL/6J mice. Brain Res Bull 2000;53:219-226.
20. Mcleod RL, Parra LE, Mutter JC, Erickson CH, Carey GJ, Tulshian DB, Fawzi AB, Smith-Torhan A, Egan RW, Cuss FM, et al. Nociceptin inhibits cough in the guinea-pig by activation of ORL1 receptors. Br J Pharmacol 2001;132:1175-1178.
21. Rizzi A, Salis MB, Ciccocioppo R, Marzola G, Bigoni R, Guerrini R, Massi M, Madeddu P, Salvadori S, Regoli D, et al. Pharmacological characterisation of [(pX)Phe4]nociceptin(1-13)NH2 analogues. 2. In vivo studies. Naunyn Schmiedebergs Arch Pharmacol 2002;365: 450-456.
22. McDonald J, Calò G, Guerrini R, Lambert DG. UFP-101, a high affinity antagonist for the nociceptin/orphanin FQ receptor: radioligand and GTPgamma(35)S binding studies. Naunyn Schmiedebergs Arch Pharmacol 2003;367:183-187.
23. Mela F, Marti M, Ulazzi L, Vaccari E, Zucchini S, Trapella C, Salvadori S, Beani L, Bianchi C, Morari M. Pharmacological profile of nociceptin/ orphanin FQ receptors regulating 5-hydroxytryptamine release in the mouse neocortex. Eur J Neurosci 2004;19:1317-1324.
24. Corboz MR, Fernandez X, Egan RW, Hey JA. Inhibitory activity of nociceptin/orphanin FQ on capsaicin-induced bronchoconstriction in the guinea-pig. Life Sci 2001;69:1203-1211.
25. Undem BJ, McAlexander M, Hunter DD. Neurobiology of the upper and lower airways. Allergy 1999;54:81-93.
26. Sanjar S, Aoki S, Kristersson A, Smith D, Morley J. Antigen challenge induces pulmonary airway eosinophil accumulation and airway hyperreactivity in sensitized guinea-pigs: the effect of anti-asthma drugs. Br J Pharmacol 1990;99:679-686.